NRF-SAIAB Student Symposium: Session 3

Value of the Information & Strength of the Argument

The talk provides valuable insights into the importance of marine natural products for drug discovery, particularly in the context of antimicrobial resistance. The speaker presents compelling arguments for the need to explore marine biodiversity, citing the high rate of new species discovery in South African waters and the potential for novel chemical compounds. The argumentation is supported by specific examples, such as keilistatin and the challenges of drug development, and by data from the speaker’s own research, including collection statistics and bioassay results. The talk also highlights the economic and societal challenges of antibiotic development, making a strong case for collaborative efforts. However, the presentation is largely based on the speaker’s expert opinion and ongoing research, with limited detailed methodological descriptions or peer-reviewed citations, which somewhat weakens the scientific rigor.

Scientific Rigor, Source Quality, Title Accuracy

The talk demonstrates a good level of scientific rigor, as the speaker is a recognized expert and presents data from her own research program. However, the sources cited are limited: she mentions a paper by Charlie Griffiths (2010) on marine biodiversity, but does not provide specific references for other claims. The talk is primarily based on the speaker’s experience and ongoing projects, which is appropriate for a symposium keynote but limits the verifiability of the information. The title accurately reflects the content, as the session focuses on marine natural products and pharmaceutical development. The talk is well-structured and provides a comprehensive overview of the research, but it lacks detailed citations and references to specific studies, which would enhance its scientific credibility.

The title accurately reflects the content: a session of a student symposium featuring a keynote lecture on marine natural products for pharmaceutical development.

7/10

The talk is delivered by a professor with deep expertise in marine natural products and antimicrobial resistance. It presents specific data from ongoing research, including collection statistics and bioassay results, but lacks detailed methodological descriptions and peer-reviewed references. The content is largely based on the speaker's own research and expert opinion, with some references to published work (e.g., Griffiths 2010) but not systematically cited.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and acknowledgment of partnerships, particularly with SAIAB and Rhodes University.
• 02:00Definition of natural products and their importance as sources of new chemical entities for drug discovery.
• 05:00Discussion of keilistatin, a potent anti-cancer compound from a marine tubeworm, and the challenges of supply.
• 10:00Overview of the drug discovery pipeline, including costs and success rates.
• 15:00Introduction of the SA-UK Antimicrobial Drug Discovery Hub and its goals.
• 20:00Description of field collections using the ROV on the RV Algoa and the ASEP sponge collection.
• 30:00Presentation of bioassay results and molecular networking to prioritize active compounds.
• 40:00Discussion of the importance of partnerships and building research capacity in Africa.

• Griffiths, C.L. (2010) - An assessment of the marine biodiversity of our coast — Referenced as a basis for understanding marine biodiversity along the South African coast.

• WHO fact sheet on antimicrobial resistance — Supports the claim that antimicrobial resistance is a top global health threat.